Filing Details

Accession Number:
0001567619-22-006948
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-14 21:22:50
Reporting Period:
2022-03-14
Accepted Time:
2022-03-14 21:22:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1305253 Eiger Biopharmaceuticals Inc. EIGR Biological Products, (No Disgnostic Substances) (2836) 361004130
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1762893 Sriram Ryali C/O Eiger Biopharmaceuticals, Inc.
2155 Park Blvd.
Palo Alto CA 94306
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-03-14 2,266 $5.60 41,566 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. These shares were sold by the reporting person in a pre-elected sell-to-cover transaction to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 14, 2022 for 5,417 shares.